Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+20.3%
5Y CAGR+3.8%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+20.3%/yr
vs -6.4%/yr prior
5Y CAGR
+3.8%/yr
Recent acceleration
Acceleration
+26.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$86.25M+22.1%
2024$70.63M+37.5%
2023$51.38M+3.6%
2022$49.59M-1.6%
2021$50.40M-29.6%
2020$71.58M+32.7%
2019$53.96M-16.6%
2018$64.68M+84.7%
2017$35.02M+35.7%
2016$25.80M-